ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,431 | +9.8% | 517 | +42.0% | 0.00% | – |
| Q2 2023 | $16,792 | +459.7% | 364 | +506.7% | 0.00% | – |
| Q4 2018 | $3,000 | – | 60 | +566.7% | 0.00% | – |
| Q3 2016 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 9 | -97.1% | 0.00% | – |
| Q1 2016 | $19,000 | -13.6% | 311 | +55.5% | 0.00% | -100.0% |
| Q4 2015 | $22,000 | -4.3% | 200 | -14.5% | 0.00% | 0.0% |
| Q3 2015 | $23,000 | -39.5% | 234 | -37.8% | 0.00% | 0.0% |
| Q2 2015 | $38,000 | +100.0% | 376 | +20.9% | 0.00% | – |
| Q1 2015 | $19,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |